Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» refractory indolent non-Hodgkins lymphoma
refractory indolent non-Hodgkins lymphoma
Allogene’s ALLO-501 Shows Positive Results in Its Phase I ALPHA Trial
BioSpace
Sat, 05/30/20 - 07:50 pm
Allogene
ASCO 2020
ALLO-501
clinical trials
refractory indolent non-Hodgkins lymphoma
Standard Review for Gilead's Oncology Candidate
Yahoo/Zacks.com
Tue, 01/14/14 - 11:52 am
Gilead Sciences
Idelalisib
refractory indolent non-Hodgkins lymphoma
FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
Yahoo
Mon, 01/13/14 - 09:41 am
FDA
Gilead Sciences
Idelalisib
refractory indolent non-Hodgkins lymphoma